ATI-501

ATI-501 · Aclaris Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATI-501, covering 2020-09-16 to 2020-09-16. Get the full timeline:

Most recent: Clinical Trial Update: ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis [Phase 2]

See pricing